These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 993322)
1. Effect of the dopamine receptor blocking agent pimozide on the growth hormone response to arginine and exercise and on the spontaneous growth hormone fluctuations. Schwinn G; Schwarck H; McIntosh C; Milstrey HR; Willms B; Köbberling J J Clin Endocrinol Metab; 1976 Nov; 43(5):1183-5. PubMed ID: 993322 [TBL] [Abstract][Full Text] [Related]
2. Reduced sensitivity to pirenzepine-induced blockade of growth hormone responses to arginine, exercise, and growth hormone-releasing hormone in type I diabetic subjects. Coiro V; Passeri M; Gardini E; Capretti L; Speroni G; Davoli C; Maffei ML; Fagnoni F; Bianconi L; Volpi R Metabolism; 1990 Jul; 39(7):668-75. PubMed ID: 2114512 [TBL] [Abstract][Full Text] [Related]
3. Effect of pimozide on levodopa-induced growth hormone release in man. Masala A; Delitala G; Alagna S; Devilla L Clin Endocrinol (Oxf); 1977 Sep; 7(3):253-6. PubMed ID: 908155 [TBL] [Abstract][Full Text] [Related]
4. Effect of dopaminergic blockade on the secretion of growth hormone and prolactin in man. Masala A; Delitala G; Alagna S; Devilla L; Rovasio PP; Lotti G Metabolism; 1978 Aug; 27(8):921-6. PubMed ID: 672613 [TBL] [Abstract][Full Text] [Related]
5. The effect of TRH, cyproheptadine and pimozide on the growth hormone response to intramuscular glucagon. Hainer V; Urbánek J; Malec B; Krejcik L Horm Metab Res; 1981 Aug; 13(8):451-3. PubMed ID: 6799379 [TBL] [Abstract][Full Text] [Related]
6. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers. Miell JP; Corder R; Pralong FP; Gaillard RC J Clin Endocrinol Metab; 1991 Mar; 72(3):675-81. PubMed ID: 1671785 [TBL] [Abstract][Full Text] [Related]
8. The effect of methysergide, pimozide, and sodium valproate on the diazepam-stimulated growth hormone secretion in man. Koulu M; Lammintausta R; Kangas L; Dahlström S J Clin Endocrinol Metab; 1979 Jan; 48(1):119-22. PubMed ID: 370137 [TBL] [Abstract][Full Text] [Related]
9. Cholinergic mediation of growth hormone secretion elicited by arginine, clonidine, and physical exercise in man. Casanueva FF; Villanueva L; Cabranes JA; Cabezas-Cerrato J; Fernandez-Cruz A J Clin Endocrinol Metab; 1984 Sep; 59(3):526-30. PubMed ID: 6746865 [TBL] [Abstract][Full Text] [Related]
10. Role of dopamine in the inhibitory control of growth hormone and prolactin release by gastrin-releasing peptide. Kentroti S; McCann SM Brain Res Bull; 1996; 39(4):201-4. PubMed ID: 8963684 [TBL] [Abstract][Full Text] [Related]
11. Effect of methysergide and pimozide on apomorphine-induced growth hormone secretion in men. Lal S; Guyda H; Bikadoroff S J Clin Endocrinol Metab; 1977 Apr; 44(4):766-70. PubMed ID: 849986 [TBL] [Abstract][Full Text] [Related]
12. Cholinergic muscarinic receptor blockade suppresses arginine- and exercise-induced growth hormone secretion in type I diabetic subjects. Arends J; Wagner ML; Willms BL J Clin Endocrinol Metab; 1988 Feb; 66(2):389-94. PubMed ID: 3339112 [TBL] [Abstract][Full Text] [Related]
13. [The effect of dopaminergic block on secretion of the growth hormone (author's transl)]. Hainer V; Krejcík L; Urbánek J; Malec J Cas Lek Cesk; 1978 May; 117(19):590-2. PubMed ID: 679233 [No Abstract] [Full Text] [Related]
14. Effect of adrenergic receptor blockade on cortisol and GH response to insulin-induced hypoglycemia in man. Jezová-Repceková D; Klimes I; Jurcovicová J; Vigas M Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):64-7. PubMed ID: 422303 [TBL] [Abstract][Full Text] [Related]
15. Impact of euglycaemia and hyperglycaemia on the release of growth hormone and prolactin in type II-diabetics. Vierhapper H; Bratusch-Marrain P; Waldhäusl W; Nowotny P; Panzer S Horm Metab Res; 1983 Jan; 15(1):24-9. PubMed ID: 6403444 [TBL] [Abstract][Full Text] [Related]
16. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics. Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515 [TBL] [Abstract][Full Text] [Related]
17. [Dopaminergic blockage using pimozide and dopaminergic stimulation using bromocryptin. Effect on secretion of somatotropin]. Hainer V; Krejcík L; Urbánek J; Tvaroh F Cas Lek Cesk; 1977 Jan; 116(2):11-6. PubMed ID: 576415 [No Abstract] [Full Text] [Related]
18. Endocrine effects of pimozide, a specific dopaminergic blocker. Collu R; Jéquier JC; Leboeuf G; Letarte J; Ducharme JR J Clin Endocrinol Metab; 1975 Nov; 41(5):981-4. PubMed ID: 171278 [TBL] [Abstract][Full Text] [Related]
19. Effect of gamma-aminobutyric acid on growth hormone and prolactin secretion in man: influence of pimozide and domperidone. Cavagnini F; Benetti G; Invitti C; Ramella G; Pinto M; Lazza M; Dubini A; Marelli A; Müller EE J Clin Endocrinol Metab; 1980 Oct; 51(4):789-92. PubMed ID: 7419665 [TBL] [Abstract][Full Text] [Related]
20. A role for dopamine in growth hormone regulation in the dog. Casanueva F; Betti R; Cocchi D; Zanardi P; Motta T; Müller EE Endocrinology; 1981 Apr; 108(4):1469-75. PubMed ID: 7472276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]